JAKARTA (Reuters) - Indonesia will not share bird flu virus samples with foreign laboratories until the World Health Organisation has rules in place to ensure they are not used commercially, a senior Indonesian health official said on Friday.
Jakarta has been criticised for moving to stop sharing the highly pathogenic H5N1 strain of the virus. It argues that the prevailing system allows drug firms to use these samples to make vaccines that developing countries often cannot afford.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
